Literature DB >> 22819549

Glucose acts as a regulator of serum iron by increasing serum hepcidin concentrations.

Elmar Aigner1, Thomas K Felder, Hannes Oberkofler, Penelope Hahne, Simon Auer, Selma Soyal, Andreas Stadlmayr, Karin Schwenoha, Christian Pirich, Paul Hengster, Christian Datz, Wolfgang Patsch.   

Abstract

Mutual clinical and molecular interactions between iron and glucose metabolism have been reported. We aimed to investigate a potential effect of glucose on iron homeostasis. We found that serum iron concentrations gradually decreased over 180 min after the administration of 75 g of glucose from 109.8 ± 45.4 mg/L to 94.4 ± 40.4 mg/L (P<.001; N=40) but remained unchanged in control subjects receiving tap water (N=21). Serum hepcidin, the key iron regulatory hormone which is mainly derived from hepatocytes but also expressed in pancreatic β-cells, increased within 120 min after glucose ingestion from 19.7 ± 9.9 nmol/L to 31.4 ± 21.0 nmol/L (P<.001). In cell culture, glucose induced the secretion of hepcidin and insulin into the supernatant of INS-1E cultures, but did not change the amount of hepcidin detectable in the hepatocyte cell culture HepG2. We additionally confirmed the expression of hepcidin in a human islet cell preparation. These results suggest that glucose acts as a regulator of serum iron concentrations, most likely by triggering the release of hepcidin from β-cells.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22819549     DOI: 10.1016/j.jnutbio.2012.02.017

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  16 in total

Review 1.  The Role of Iron in Type 1 Diabetes Etiology: A Systematic Review of New Evidence on a Long-Standing Mystery.

Authors:  Karen L Søgaard; Christina Ellervik; Jannet Svensson; Steffen U Thorsen
Journal:  Rev Diabet Stud       Date:  2017-10-10

Review 2.  Serum hepcidin concentrations and type 2 diabetes.

Authors:  Alex Aregbesola; Sari Voutilainen; Jyrki K Virtanen; Adeola Aregbesola; Tomi-Pekka Tuomainen
Journal:  World J Diabetes       Date:  2015-07-10

3.  Tipping the balance: Haemoglobinopathies and the risk of diabetes.

Authors:  Henry J Baldwin; Aislinn E Green; Kayleigh M Spellar; Philip J Arthur; Hannah G Phillips; Jeetesh V Patel
Journal:  World J Diabetes       Date:  2016-01-10

Review 4.  Pleiotropic actions of iron balance in diabetes mellitus.

Authors:  Xinhui Wang; Xuexian Fang; Fudi Wang
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

Review 5.  The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients.

Authors:  Kimberly Zumbrennen-Bullough; Jodie L Babitt
Journal:  Nephrol Dial Transplant       Date:  2013-11-13       Impact factor: 5.992

Review 6.  Physiology of iron metabolism.

Authors:  Sophie Waldvogel-Abramowski; Gérard Waeber; Christoph Gassner; Andreas Buser; Beat M Frey; Bernard Favrat; Jean-Daniel Tissot
Journal:  Transfus Med Hemother       Date:  2014-05-12       Impact factor: 3.747

7.  Increased hepcidin expression in non-small cell lung cancer tissue and serum is associated with clinical stage.

Authors:  Qian Chen; Li Wang; Yuchao Ma; Xianning Wu; Longyu Jin; Fenglei Yu
Journal:  Thorac Cancer       Date:  2014-01-02       Impact factor: 3.500

Review 8.  Out of balance--systemic iron homeostasis in iron-related disorders.

Authors:  Andrea U Steinbicker; Martina U Muckenthaler
Journal:  Nutrients       Date:  2013-08-02       Impact factor: 5.717

9.  Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer's Disease.

Authors:  Zohara Sternberg; Zihua Hu; Daniel Sternberg; Shayan Waseh; Joseph F Quinn; Katharine Wild; Kaye Jeffrey; Lin Zhao; Michael Garrick
Journal:  Aging Dis       Date:  2017-04-01       Impact factor: 6.745

10.  Hepcidin links gluco-toxicity to pancreatic beta cell dysfunction by inhibiting Pdx-1 expression.

Authors:  Xuhua Mao; Hucheng Chen; Junmin Tang; Liangliang Wang; Tingting Shu
Journal:  Endocr Connect       Date:  2017-02-08       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.